Accumulated evidence has demonstrated that some ncRNAs play important regulatory roles in the key signaling pathways associated with AD pathology, including Aβ aggregation/production, tau hyperphosphorylation, neuroinflammation, synaptic failure and mitochondrial dysfunction [75,76,77]. This evidence concerns the gene MAPT and Alzheimer disease.